Names | |
---|---|
IUPAC name
4-aminobutanoic acid
|
|
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.000.235 |
EC Number | 200-258-6 |
KEGG | |
MeSH | gamma-Aminobutyric+Acid |
PubChem CID
|
|
RTECS number | ES6300000 |
UNII | |
|
|
|
|
Properties | |
C4H9NO2 | |
Molar mass | 103.120 g/mol |
Appearance | white microcrystalline powder |
Density | 1.11 g/mL |
Melting point | 203.7 °C (398.7 °F; 476.8 K) |
Boiling point | 247.9 °C (478.2 °F; 521.0 K) |
130 g/100 mL | |
log P | −3.17 |
Acidity (pKa) | 4.23 (carboxyl), 10.43 (amino) |
Hazards | |
Main hazards | Irritant, Harmful |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
12,680 mg/kg (mouse, oral) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
gamma-Aminobutyric acid (γ-Aminobutyric acid) /ˈɡæmə əˈmiːnoʊbjuːˈtɪrɪk ˈæsɪd/ (GABA /ˈɡæbə/) is the chief inhibitory neurotransmitter in the mammalian central nervous system. Its principal role is reducing neuronal excitability throughout the nervous system. In humans, GABA is also directly responsible for the regulation of muscle tone.
Although in chemical terms it is an amino acid (as it has both a primary amine and a carboxylic acid functional group), GABA is rarely referred to as such in the scientific or medical community. By convention the term "amino acid", when used without a qualifier, refers specifically to an alpha amino acid. GABA is not an alpha amino acid, meaning the amino group is not attached to the alpha carbon so it is not incorporated into proteins.